The U.S. Food and Drug Administration’s full approval of the Pfizer-BioNTech coronavirus vaccine for people 16 and older could embolden more employers to require vaccination and certainly weakens employees’ attempts to litigate the issue.

Despite the win for employers, attorneys continue to advise treading lightly when considering a vaccine mandate.

The Driver: